Wall Street Zen Upgrades Adtalem Global Education (NYSE:CVSA) to “Buy”

Adtalem Global Education (NYSE:CVSA) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday.

A number of other equities analysts have also recently issued reports on CVSA. Barrington Research reaffirmed an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a report on Monday, June 8th. Truist Financial raised their price target on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $155.00.

Adtalem Global Education Stock Performance

NYSE CVSA opened at $140.84 on Friday. The business’s fifty day moving average is $124.68. The company has a market capitalization of $4.79 billion, a PE ratio of 20.01, a PEG ratio of 1.05 and a beta of 0.62. Adtalem Global Education has a fifty-two week low of $86.97 and a fifty-two week high of $156.26. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.45.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings results on Thursday, August 6th. The company reported $2.09 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The company had revenue of $501.38 million during the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, sell-side analysts predict that Adtalem Global Education will post 8.95 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Robert J. Phelan sold 2,900 shares of Adtalem Global Education stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $135.41, for a total value of $392,689.00. Following the completion of the sale, the chief financial officer owned 52,906 shares of the company’s stock, valued at approximately $7,164,001.46. This trade represents a 5.20% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Douglas G. Beck sold 2,650 shares of the business’s stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $135.40, for a total transaction of $358,810.00. Following the sale, the senior vice president owned 35,509 shares of the company’s stock, valued at $4,807,918.60. This trade represents a 6.94% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 15,694 shares of company stock worth $2,098,614 in the last ninety days. Corporate insiders own 2.50% of the company’s stock.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.